ConductScience.org, home

Paper · 41565619

Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression.

Li X and 9 others. Cell Death Dis, 2026. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression. Papers, record 41565619. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41565619

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Positive feedback regulation between USP8 and Hippo/YAP axis drives triple-negative breast cancer progression.
PubMed
Journal
Cell Death Dis
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-06-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li XXinhttps://orcid.org/0009-0007-3315-3408
2Yang PPenghe
3Wang TTianshi
4Su PPenghttps://orcid.org/0000-0002-7000-0474
5Zhang CChenmiao
6Fangyu SShen
7Yang HHuijie
8Zhu JJianhttps://orcid.org/0000-0003-3596-4339
9Tan XXiaodonghttps://orcid.org/0000-0003-0862-1306
10Zhuang TTinghttps://orcid.org/0000-0002-6308-1253

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Triple Negative Breast NeoplasmsMajor topic
Protein Serine-Threonine KinasesMajor topic
Ubiquitin ThiolesteraseMajor topic
Adaptor Proteins, Signal TransducingMajor topic
Transcription FactorsMajor topic
Feedback, PhysiologicalMajor topic
EndopeptidasesMajor topic
PhosphoproteinsMajor topic
Humans
Female
Hippo Signaling Pathway
YAP-Signaling Proteins
Ubiquitination
Signal Transduction
Cell Line, Tumor
Disease Progression
Gene Expression Regulation, Neoplastic
Animals
Endosomal Sorting Complexes Required for Transport

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,443,516Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.Cells2019https://conductscience.org/library/papers/31443516PubMed
236,759,723The oncogenic roles and clinical implications of YAP/TAZ in breast cancer.Br J Cancer2023https://conductscience.org/library/papers/36759723PubMed
319,008,097What is triple-negative breast cancer?Eur J Cancer2008https://conductscience.org/library/papers/19008097PubMed
435,361,799USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy.Nat Commun2022https://conductscience.org/library/papers/35361799PubMed
532,863,938Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.Theranostics2020https://conductscience.org/library/papers/32863938PubMed
631,765,611GDF15 induced by compressive force contributes to osteoclast differentiation in human periodontal ligament cells.Exp Cell Res2020https://conductscience.org/library/papers/31765611PubMed
727,485,598Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium.Carcinogenesis2016https://conductscience.org/library/papers/27485598PubMed
834,813,758Deubiquitinases: From mechanisms to their inhibition by small molecules.Mol Cell2022https://conductscience.org/library/papers/34813758PubMed
932,206,112A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy.Theranostics2020https://conductscience.org/library/papers/32206112PubMed
1035,811,497USP8 promotes cancer progression and extracellular vesicle-mediated CD8+ T cell exhaustion by deubiquitinating the TGF-β receptor TβRII.EMBO J2022https://conductscience.org/library/papers/35811497PubMed

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41,926,654Tetrastigma Hemsleyanum Polysaccharide Suppresses Triple-Negative Breast Cancer by Disrupting the Hippo-YAP/TEAD4-PDIA4 Axis and Endoplasmic Reticulum Stress Adaptation.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41926654

Source PubMed

Genes17

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41565619

GET https://conductscience.org/api/papers/v1/41565619/references?page=2